Navigation Links
Depression increases risk for heart disease more than genetics or environment
Date:3/4/2009

A history of major depression increases the risk of heart disease over and above any genetic risks common to depression and heart disease, according to researchers at Washington University School of Medicine in St. Louis and the VA. The findings are reported this week at the annual meeting of the American Psychosomatic Society this week in Chicago.

The researchers analyzed data gathered from more than 1,200 male twins who served in the U.S. military during the Vietnam War. The men were surveyed on a variety of health issues in 1992, including depression, and were assessed again in 2005.

In the study, investigators looked at the onset of heart disease in depressed study participants between 1993 and 2005. Men with depression in 1992 were twice as likely to develop heart disease in the ensuing years, compared to men with no history of depression.

"Based on our findings, we can say that after adjusting for other risk factors, depression remains a significant predictor of heart disease," says first author Jeffrey F. Scherrer, Ph.D., research assistant professor of psychiatry at Washington University School of Medicine and the St. Louis Veterans Affairs Medical Center. "In this study, we have demonstrated that exposure to depression is contributing to heart disease only in twins who have high genetic risk and who actually develop clinical depression. In twins with high genetic risk common to depression and heart disease, but who never develop depression itself, there was no increased risk for heart disease. The findings strongly suggest that depression itself independently contributes to risk for heart disease."

The investigators were looking for evidence of what they call incident heart disease, an event such as a heart attack, heart surgery, stent placement or medical treatment for angina. Those who had evidence of heart disease prior to the original survey in 1992 were excluded from this study.

Because twins were studied, the researchers could divide participants into risk groups: twins with high genetic and environmental risk for depression, those with moderate risk and those with a low risk. The risk groups then were compared for incident heart disease adjusting for other influences on heart disease such as smoking, obesity, hypertension and diabetes.

"By separating the twins into these groups based on their genetic and environmental risks, we are able differentiate the genetic risks common to depression and heart disease and the risks for heart disease from exposure to depression," says co-investigator Hong Xian, Ph.D., associate professor of mathematics in medicine at Washington University and health science specialist at the VA.

Twins automatically are matched by age. They normally grow up in the same family environment, and in the case of identical twins, they share identical DNA.

"If one twin has depression, but his twin brother does not, both twins will share genetic vulnerability for depression, but it turns out the twin who was not depressed has less risk for heart disease," says Scherrer. "In sum, depression itself remains a significant contributor to incident heart disease after controlling for genes, environment and mental and physical risk factors."

Scherrer and Xian plan to follow these twins as they age. They also plan to study the effects of successful depression treatment on heart disease risk.


'/>"/>

Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
Source:Eurekalert

Related medicine news :

1. Clinical depression linked to abnormal emotional brain circuits
2. Depression Taking Toll on Returning U.S. Vets
3. Damp, Moldy Homes May Cause Depression
4. Treating depression may improve recovery of heart rate variability following coronary syndromes
5. Study finds primary care depression treatment often does not follow quality guidelines
6. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
7. Depression May Be Worlds Most Disabling Disease
8. Depression Pushes Middle-Aged Workers to Retire
9. Maternal depression and controlling behavior associated with increased stress response in infants
10. Brain atrophy in elderly leads to unintended racism, depression and problem gambling
11. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: